GIANNELLI, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 10.046
EU - Europa 1.939
AS - Asia 1.261
SA - Sud America 63
OC - Oceania 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.320
Nazione #
US - Stati Uniti d'America 10.017
CN - Cina 725
SE - Svezia 619
SG - Singapore 434
IT - Italia 270
UA - Ucraina 249
DE - Germania 243
FI - Finlandia 180
GB - Regno Unito 160
FR - Francia 61
BR - Brasile 55
BE - Belgio 54
IE - Irlanda 32
IN - India 27
CA - Canada 22
VN - Vietnam 21
CZ - Repubblica Ceca 18
NL - Olanda 15
IR - Iran 14
JP - Giappone 11
RU - Federazione Russa 7
HK - Hong Kong 6
LT - Lituania 5
AU - Australia 4
BD - Bangladesh 4
ES - Italia 4
RO - Romania 4
AR - Argentina 3
AT - Austria 3
HU - Ungheria 3
IQ - Iraq 3
MX - Messico 3
AM - Armenia 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
EU - Europa 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 13.320
Città #
Fairfield 1.404
Chandler 1.135
Woodbridge 1.075
Ashburn 739
Houston 653
Jacksonville 565
Seattle 554
Wilmington 517
Nyköping 511
Cambridge 480
Ann Arbor 402
Singapore 304
Lawrence 208
Roxbury 202
Beijing 169
Nanjing 167
New York 125
Des Moines 110
Boardman 99
Inglewood 79
Princeton 77
San Diego 67
Los Angeles 55
Brooklyn 54
Bari 52
Brussels 52
Jiaxing 44
London 41
Santa Clara 41
Helsinki 39
Hebei 38
Shenyang 36
Tianjin 33
Dublin 32
Nanchang 32
Munich 27
Changsha 22
Paris 22
Shanghai 22
Washington 22
Redwood City 20
Dong Ket 19
Falls Church 17
San Mateo 17
Olomouc 15
Pune 15
Dearborn 14
Norwalk 13
Ardabil 12
Guangzhou 12
Toronto 12
Augusta 11
Grumo Appula 10
Hangzhou 10
Milan 10
Edinburgh 9
Jinan 9
Kilburn 9
Leawood 9
San Francisco 9
Strasbourg 9
Ostuni 8
Zhengzhou 8
Taranto 7
Tokyo 7
Frankfurt am Main 6
Ottawa 6
Rome 6
Amsterdam 5
Auburn Hills 5
Hong Kong 5
Marseille 5
New Bedfont 5
Ningbo 5
Prescot 5
Romola 5
Stockholm 5
Taizhou 5
Wuhan 5
Chiswick 4
Grafing 4
Hanover 4
Islington 4
Monmouth Junction 4
Naples 4
Redmond 4
Romainville 4
Torrile 4
Triggiano 4
Yiwu 4
Brescia 3
Brno 3
Budapest 3
Dhaka 3
Fortaleza 3
Genoa 3
Hounslow 3
Jinhua 3
Kingston 3
Kunming 3
Totale 10.744
Nome #
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 132
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 132
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 130
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 130
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 121
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 120
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 118
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 115
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: A prospective clinical study 115
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 108
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 107
Immune cells and microbiota response to iron starvation 105
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 103
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 102
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 100
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 98
.: Cancer invasion: watch your neighbourhood! 98
TGF-β and the tissue microenvironment: Relevance in fibrosis and cancer 97
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 94
The TGF-β pathway: a pharmacological target in hepatocellular carcinoma? 94
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 93
Dietary ω-3 polyunsaturated fatty acids inhibit tumor growth in transgenic Apcmin/+ mice, correlating with CB1 receptor up-regulation 92
Novel Transforming Growth Factor Beta Receptor I Kinase Inhibitor Galunisertib (LY2157299) in Advanced Hepatocellular Carcinoma 90
Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids 89
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. 89
Rationale for new drugs targeting the tissue microenvironment in patients with HCC 88
Malignant fibrous histiocytoma arising on chronic osteomyelitis 88
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 88
Signaling networks in cholangiocarcinoma: molecular pathogenesis, targeted therapies and drug resistance 88
FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation 88
Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex-vivo cultures 87
Automatic transwell assay by an EIS cell chip to monitor cell migration 87
Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: Results from a preclinical pilot study 87
Aquaporin 9 contributes to the maturation process and inflammatory cytokine secretion of murine dendritic cells 86
null 86
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease 85
Aerobic physical activity and a low glycemic diet reduce the AA/EPA ratio in red blood cell membranes of patients with NAFLD 85
Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model 85
Polymeric nano-micelles as novel cargo-carriers for LY2157299 liver cancer cells delivery 85
Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib 84
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production 84
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors 84
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 84
Case of multiple myeloma mimicking an infectious disease with fever, intrahepatic cholestasis, renal failure, and pulmonary insufficiency 83
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 82
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment 82
Transforming growth factor-β promotes morphomechanical effects involved in epithelial to mesenchymal transition in living hepatocellular carcinoma 82
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy 81
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 81
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-a 80
Gelatinase levels in male and female breast cancer 79
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 79
TGF-Beta Inihibitor-loaded Polyelectrolyte Multilayers Capsules for Sustained Targeting of Hepatocarcinoma Cells 79
2',5’-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C 78
Valore prognostico della neopterina nel siero di soggetti con infezione da HIV 78
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 78
The epithelial-mesenchymal transition: fact or fiction in cancer? 77
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 77
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients 77
PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments 77
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 76
Glaucoma in primary amyloidosis:a fortuitous or a causative association? 76
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. 76
MxA and PKR expression in chronic hepatitis C 76
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 75
The rationale for targeting TGF-β in chronic liver diseases 75
ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells 75
null 75
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 73
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection 73
Key enabling technologies for point-of-care diagnostics 72
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 72
null 72
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 71
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals 71
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link? 70
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 70
SCCA Antigen combined with alpha-fetoprotein as serologic markers of HCC 70
null 70
null 70
Dietary fiber and health outcomes: An umbrella review of systematic reviews and meta-analyses 70
Coffee intake and liver steatosis: A population study in a mediterranean area 70
Effects of interferon-alfa treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C 69
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism 69
Clinical outcomes of bosentan in pulmonary arterial hypertension do not correlate with levels of TIMPs 68
MxA and PKR expression in chronic hepatitis C 68
null 68
Association between adherence to the Mediterranean Diet and circulating Vitamin D levels 68
The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension 67
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study 66
Proteolytic balance in patients with multiple sclerosis during interferon treatment 66
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. 66
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 66
Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy 66
Nutritional domains in frailty tools: Working towards an operational definition of nutritional frailty 66
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 65
Characterization of morphological and cytoskeletal changes in MCF10A breast epithelial cells plated on laminin-5: comparison with breast cancer cell line MCF7 64
New frontiers in biomarkers for hepatocellular carcinoma 64
Differential tissue fatty acids profiling between colorectal cancer patients with and without synchronous metastasis 64
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients 63
Totale 8.362
Categoria #
all - tutte 66.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.855 0 0 0 0 0 199 334 325 414 225 247 111
2020/20212.175 156 150 135 215 270 114 183 179 156 290 168 159
2021/20221.474 78 163 31 81 70 113 66 102 107 85 241 337
2022/20232.793 365 303 192 280 353 345 26 318 451 26 89 45
2023/2024982 66 178 61 78 84 233 47 34 15 44 18 124
2024/20251.033 91 81 327 180 173 181 0 0 0 0 0 0
Totale 13.806